Early diagnosis of Alzheimer's may be possible with artificial intelligence and sleep analysis
要点
- Researchers from the Madrid Carlos III University and Severo Ochoa Hospital have developed a new AI-based diagnostic method.
- The new method detects early neurological changes by analyzing brain waves during sleep.
- Thanks to machine learning, patients can be non-invasively divided into three different biological subgroups.
- The study was recently published in the scientific journal GeroScience.
数据一览
Researchers from the Madrid Carlos III University (UC3M) and the Severo Ochoa University Hospital have developed a new method that uses artificial intelligence to examine the brain's electrical activity during sleep. This innovative approach aims to facilitate the early diagnosis of Alzheimer's disease.
According to the study published in the journal GeroScience, the analysis of nighttime brain waves using machine learning techniques can detect early neural changes. The developed method offers the possibility of non-invasively classifying patients into three different biological subgroups.
The integration of this methodology into clinical applications could increase the success of early intervention processes, which are of critical importance in progressive neurological disorders such as Alzheimer's. This situation creates a new window of opportunity for treatment methods that will change the course of the disease.
对这条新闻做出反应
询问这条新闻
回答由AI仅根据本新闻生成。
常见问题
- How does the newly developed method work in diagnosing Alzheimer's?
- By using artificial intelligence and machine learning, it analyzes the electrical brain activity of patients during sleep and detects early neural changes.
- Which institutions conducted the research?
- It was conducted in collaboration with researchers from the Madrid Carlos III University (UC3M) and the Severo Ochoa University Hospital, affiliated with the Madrid public health network.
- How does the artificial intelligence analysis classify patients?
- Using data obtained from nighttime brain waves, the artificial intelligence model non-invasively divides Alzheimer's patients into three different biological subgroups.